Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Published-Ahead-of-Print April 2, 2009, DOI:10.2164/jandrol.108.006296

This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
30/5/602    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kornmann, B.
Right arrow Articles by Von Eckardstein, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kornmann, B.
Right arrow Articles by Von Eckardstein, S.

Body Fat Content and Testosterone Pharmacokinetics Determine Gonadotropin Suppression after Intramuscular Injections of Testosterone Preparations in Normal Men

Britta Kornmann , Eberhard Nieschlag *, Michael Zitzmann , Joerg Gromoll , Manuela Simoni , and Sigrid Von Eckardstein

* To whom correspondence should be addressed. E-mail: eberhard.nieschlag{at}ukmuenster.de.

Interindividual differences in gonadotropin suppression achieved by a short and a long-acting intramuscular testosterone (T) preparation were studied to detect factors hindering complete suppression of gonadotropins as the prerequisite for effective male contraception. 40 healthy men received a single injection of testosterone propionate (TP) and four weeks later, two injections of 1000 mg testosterone undecanoate (TU) given six weeks apart. Following TU, decline of LH and FSH was consistent in 17.5% and almost absent in 25% of men. Men showing the most rapid and consistent decline in LH and FSH received a slightly higher dose per bodyweight of TU (13.1 ± 0.6 vs.11.3 ± 0.6 mg/kg; n.s.) and reached higher maximal concentrations of total T (40 ± 4.8 vs. 18.4 ± 2.4 nmol/L; p<0.001) and free T as well as estradiol. Men with high fat mass (mean ± SEM: 10.3 ± 1.5 vs. 23.2 ± 6.4 kg) had a delayed increase in T levels and an impaired relative decline in LH (12 ± 2% vs. 53 ± 10%) and FSH (17 ± 6%. vs. 70 ± 25%) within the first two weeks after the first TU injection. We conclude that overweight reduces the chance of rapid and profound gonadotropin suppression during treatment with TU. Body weight needs to be considered to avoid failure of hormonal male contraception.


Key words: Gonadotropins • Testosterone • body fat • negative feed back • pharmacokinetics






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by The American Society of Andrology.